MedTrace Logo

Pilot Study of Colon Cancer Screening Tests

NCT00865527 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 198

Last updated 2016-03-31

No results posted yet for this study

Summary

Colon cancer is the second leading cause of cancer death in North America. These deaths are preventable with proper screening. Fecal occult blood testing, virtual colonoscopy, and standard (optical) colonoscopy are all options for colon cancer screening, but it is not known which is the best at preventing death from colon cancer. A large study comparing these three tests is desperately needed. In this pilot study, the investigators want to find out what percentage of patients will show up for their screening test once enrolled. This will provide crucial information for the successful execution of the larger study.

Conditions

Interventions

OTHER

Fecal occult blood test

FOBT

PROCEDURE

Virtual colonoscopy

computed tomographic colonography

PROCEDURE

Optical colonoscopy

optical (conventional / endoscopic) colonoscopy

Sponsors & Collaborators

Principal Investigators

  • John J You, MD MSc FRCPC · McMaster University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2011-03-31
Completion
2011-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00865527 on ClinicalTrials.gov